Literature DB >> 707532

Persistent bacteremia in staphylococcal endocarditis.

M T Reymann, H P Holley, C G Cobbs.   

Abstract

We treated five patients with persistent Staphylococcus aureus bacteremia and endocarditis. Surgical intervention or a "second-line" antistaphylococcal agent was required for bacteriologic cure in each. Special bacteriologic evaluation failed to demonstrate methicillin resistance or antibiotic "tolerance" among the strains of Staphylococcus tested. Cephalosporin agents were noted to be more susceptible to inoculum effect than either methicillin or nafcillin. All patients survived; the explanation for their atypical course is obscure. We present an approach to patients with persistent Staph. aureus bacteremia and endocarditis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 707532     DOI: 10.1016/0002-9343(78)90790-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid.

Authors:  A Trampuz; M Wenk; Z Rajacic; W Zimmerli
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Inoculum effect of β-lactam antibiotics.

Authors:  Justin R Lenhard; Zackery P Bulman
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

3.  Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.

Authors:  R C Mercier; H H Houlihan; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

4.  Significance of methicillin tolerance in experimental staphylococcal endocarditis.

Authors:  P L Goldman; R G Petersdorf
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

5.  Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.

Authors:  M R Bibler; P T Frame; D N Hagler; R B Bode; J L Staneck; V Thamlikitkul; J E Harris; A Haregewoin; W E Bullock
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

6.  Penicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and nontolerant Streptococcus mitis.

Authors:  F D Lowy; E G Neuhaus; D S Chang; N H Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

7.  Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.

Authors:  G Perdikaris; H Giamarellou; A Pefanis; I Donta; P Karayiannakos
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.